Amanote Research
Register
Sign In
Roles of Fhit and P53 in Taiwanese Surgically Treated Non-Small-Cell Lung Cancers
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6601041
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2003
Authors
Y-L Chang
C-T Wu
J-Y Shih
Y-C Lee
Publisher
Springer Science and Business Media LLC
Related search
Clinical Significance of P53 Alterations in Surgically Treated Prostate Cancers
Modern Pathology
Forensic Medicine
Pathology
P53 and Angiogenesis in Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Effects of Biological Markers on Overall Survival in Surgically Treated Patients With Non Small Cell Lung Cancer
Vojnosanitetski Pregled
Medicine
Pharmacology
Mechanisms of P16INK4A Inactivation in Non Small-Cell Lung Cancers
Oncogene
Cancer Research
Genetics
Molecular Biology
Hot Spot Mutations in Finnish Non-Small Cell Lung Cancers
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P1.16-56 Prognostic Ability of New T1 Descriptors in the TNM Classification of Surgically Treated Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Emerging Roles of Nrf2 Signal in Non-Small Cell Lung Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Topographical Distributions of Allelic Loss in Individual Non-Small-Cell Lung Cancers
American Journal of Pathology
Forensic Medicine
Pathology
The Relationship Between Aberrant Methylation and Survival in Non-Small-Cell Lung Cancers
British Journal of Cancer
Cancer Research
Oncology